37 Einträge gefunden

1. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.

   1. Siegerink, Bob
   2. Maas, Renke
   3. Vossen, Carla Y
   4. Schwedhelm, Edzard
   5. Koenig, Wolfgang
   6. Böger, Rainer
   7. Rothenbacher, Dietrich

   2013 - Forschungsinformationssystem des UKE
2. Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.

   1. Lüneburg, Nicole
   2. von Holten, Rouven-Alexander
   3. Töpper, Rudolf F
   4. Schwedhelm, Edzard
   5. Maas, Renke
   6. Böger, Rainer

   2012 - Forschungsinformationssystem des UKE
3. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.

   1. Tripepi, Giovanni
   2. Francesco, Mattace Raso
   3. Sijbrands, Eric
   4. Seck, Mohamed Sidy
   5. Maas, Renke
   6. Böger, Rainer
   7. Witteman, Jacqueline

   2011 - Forschungsinformationssystem des UKE
4. Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.

   1. Schwedhelm, Edzard
   2. Xanthakis, Vanessa
   3. Maas, Renke
   4. Sullivan, Lisa M
   5. Atzler, Dorothee
   6. Lüneburg, Nicole
   7. Glazer, Nicole L

   2011 - Forschungsinformationssystem des UKE
5. Stable isotope dilution assay for liquid chromatography-tandem mass spectrometric determination of L-homoarginine in human plasma.

   1. Atzler, Dorothee
   2. Mieth, Maren
   3. Maas, Renke
   4. Böger, Rainer
   5. Schwedhelm, Edzard

   2011 - Forschungsinformationssystem des UKE
6. Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.

   1. Böger, Rainer
   2. Endres, H G
   3. Schwedhelm, Edzard
   4. Darius, H
   5. Atzler, Dorothee
   6. Lüneburg, Nicole
   7. von Stritzky, B

   2011 - Forschungsinformationssystem des UKE
7. Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort.

   1. Lüneburg, Nicole
   2. Xanthakis, Vanessa
   3. Schwedhelm, Edzard
   4. Sullivan, Lisa M
   5. Maas, Renke
   6. Anderssohn, Maike
   7. Riederer, Ulrich

   2011 - Forschungsinformationssystem des UKE
8. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia.

   1. Böger, Rainer
   2. Diemert, Anke
   3. Schwedhelm, Edzard
   4. Lüneburg, Nicole
   5. Maas, Renke
   6. Hecher, Kurt

   2010 - Forschungsinformationssystem des UKE
9. Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.

   1. Jacobi, Johannes
   2. Maas, Renke
   3. Cardounel, Arturo J
   4. Arend, Michaela
   5. Pope, Arthur J
   6. Cordasic, Nada
   7. Heusinger-Ribeiro, Juliane

   2010 - Forschungsinformationssystem des UKE
10. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.

    1. Schulze, Friedrich
    2. Carter, Angela M
    3. Schwedhelm, Edzard
    4. Ajjan, Ramzi
    5. Maas, Renke
    6. von Holten, Rouven-Alexander
    7. Atzler, Dorothee

    2010 - Forschungsinformationssystem des UKE
11. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.

    1. Schulze, Friedrich
    2. Glos, Sabrina
    3. Petruschka, Dörte
    4. Altenburg, Christiane
    5. Maas, Renke
    6. Benndorf, Ralf
    7. Schwedhelm, Edzard

    2009 - Forschungsinformationssystem des UKE
12. Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study.

    1. Pikula, Aleksandra
    2. Böger, Rainer
    3. Beiser, Alexa S
    4. Maas, Renke
    5. DeCarli, Charles
    6. Schwedhelm, Edzard
    7. Himali, Jayandra J

    2009 - Forschungsinformationssystem des UKE
13. Asymmetric dimethylarginine predicts outcome and time of stay in hospital in patients attending an internal medicine emergency room.

    1. Schulze, Friedrich
    2. Vollert, Jörn
    3. Maas, Renke
    4. Müller, Reinhold
    5. Schwedhelm, Edzard
    6. Müller, Christian
    7. Böger, Rainer

    2009 - Forschungsinformationssystem des UKE
14. Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort.

    1. Schwedhelm, Edzard
    2. Xanthakis, Vanessa
    3. Maas, Renke
    4. Sullivan Lisa, M
    5. Schulze, Friedrich
    6. Riederer, Ulrich
    7. Benndorf, Ralf

    2009 - Forschungsinformationssystem des UKE
15. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk.

    1. Böger, Rainer
    2. Maas, Renke
    3. Schulze, Friedrich
    4. Schwedhelm, Edzard

    2009 - Forschungsinformationssystem des UKE
16. Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort.

    1. Maas, Renke
    2. Xanthakis, Vanessa
    3. Polak, Joseph F
    4. Schwedhelm, Edzard
    5. Sullivan Lisa, M
    6. Benndorf, Ralf
    7. Schulze, Friedrich

    2009 - Forschungsinformationssystem des UKE
17. Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample.

    1. Lieb, Wolfgang
    2. Benndorf, Ralf
    3. Benjamin, Emelia J
    4. Sullivan Lisa, M
    5. Maas, Renke
    6. Xanthakis, Vanessa
    7. Schwedhelm, Edzard

    2009 - Forschungsinformationssystem des UKE
18. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.

    1. Böger, Rainer
    2. Sullivan Lisa, M
    3. Schwedhelm, Edzard
    4. Wang, Thomas J
    5. Maas, Renke
    6. Benjamin, Emelia J
    7. Schulze, Friedrich

    2009 - Forschungsinformationssystem des UKE
19. Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice.

    1. Jacobi, Johannes
    2. Maas, Renke
    3. Cordasic, Nada
    4. Koch, Kilian
    5. Schmieder, Roland E
    6. Böger, Rainer
    7. Hilgers, Karl F

    2008 - Forschungsinformationssystem des UKE
20. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.

    1. Schwedhelm, Edzard
    2. Maas, Renke
    3. Freese, Ralf
    4. Jung, Donald
    5. Lukacs, Zoltan
    6. Jambrecina, Alen
    7. Spickler, William

    2008 - Forschungsinformationssystem des UKE